-
A Senate hearing on Tuesday featuring pharmaceutical executives will tackle many issues raised in the historic Kefauver hearings, which led to tougher drug regulation. High prices remain a concern.
-
It was not the centerpiece, but health was a persistent theme in President Donald Trump’s State of the Union address at the Capitol on Tuesday night.
-
-
-
For years, most pharmacists couldn’t give customers even a clue about an easy way to save money on prescription drugs. But the restraints are coming off...
-
-
Legal analysts say the decision to overturn Maryland's law could slow momentum for other states that are attempting to take action to curb high drug costs.
-
The Department of Justice and 45 states allege that generic- drug makers colluded to divvy up customers and set prices. Prosecutors are now looking at potential involvement by drug distributors.
-
The Trump administration rolled out a list of actions in its budget proposal to attack drug prices, but most of the measures dance around the edges of the problem.
-
The Pharmaceutical Research and Manufacturers of America, the brand-name drug industry's main trade group, spent liberally to shift the conversation on prices during the last presidential campaign.
-
Two congressmen met with President Trump seeking support for a bill to expand the government's ability to negotiate drug prices. But it's not clear it would have much impact or will gain support.